Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Mast cell-derived plasminogen activator inhibitor type 1 promotes airway inflammation and remodeling in a murine model of asthma.

Jo A, Lee SH, Kim DY, Hong SJ, Teng MN, Kolliputi N, Lockey RF, Schleimer RP, Cho SH.

J Allergy Clin Immunol. 2018 Jul;142(1):294-297.e5. doi: 10.1016/j.jaci.2018.01.040. Epub 2018 Mar 2. No abstract available. Erratum in: J Allergy Clin Immunol. 2018 Nov;142(5):1678.

2.

Zika virus: An emerging infectious disease with serious perinatal and neurologic complications.

Casale TB, Teng MN, Morano JP, Unnasch T, Lockwood CJ.

J Allergy Clin Immunol. 2018 Feb;141(2):482-490. doi: 10.1016/j.jaci.2017.11.029. Epub 2017 Dec 19. Review.

PMID:
29273403
3.

Human passive cutaneous anaphylaxis in the 21st century: Worth the risk?

Lockey RF, Teng MN.

J Allergy Clin Immunol. 2017 Jun;139(6):1795-1796. doi: 10.1016/j.jaci.2017.01.012. Epub 2017 Mar 1. No abstract available.

PMID:
28259447
4.

Use of Minigenome Systems to Study RSV Transcription.

Teng MN, Tran KC.

Methods Mol Biol. 2016;1442:155-64. doi: 10.1007/978-1-4939-3687-8_11.

PMID:
27464693
5.

Identification of Respiratory Syncytial Virus Nonstructural Protein 2 Residues Essential for Exploitation of the Host Ubiquitin System and Inhibition of Innate Immune Responses.

Whelan JN, Tran KC, van Rossum DB, Teng MN.

J Virol. 2016 Jun 24;90(14):6453-6463. doi: 10.1128/JVI.00423-16. Print 2016 Jul 15.

6.

Functional correlations of respiratory syncytial virus proteins to intrinsic disorder.

Whelan JN, Reddy KD, Uversky VN, Teng MN.

Mol Biosyst. 2016 Apr 26;12(5):1507-26. doi: 10.1039/c6mb00122j.

7.

Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures.

Johnson SM, McNally BA, Ioannidis I, Flano E, Teng MN, Oomens AG, Walsh EE, Peeples ME.

PLoS Pathog. 2015 Dec 11;11(12):e1005318. doi: 10.1371/journal.ppat.1005318. eCollection 2015 Dec.

8.

Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.

Villenave R, Broadbent L, Douglas I, Lyons JD, Coyle PV, Teng MN, Tripp RA, Heaney LG, Shields MD, Power UF.

J Virol. 2015 Dec;89(24):12309-18. doi: 10.1128/JVI.02119-15. Epub 2015 Sep 30.

9.

Human respiratory syncytial virus non-structural protein NS1 modifies miR-24 expression via transforming growth factor-β.

Bakre A, Wu W, Hiscox J, Spann K, Teng MN, Tripp RA.

J Gen Virol. 2015 Nov;96(11):3179-91.

10.

A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5).

Phan SI, Chen Z, Xu P, Li Z, Gao X, Foster SL, Teng MN, Tripp RA, Sakamoto K, He B.

Vaccine. 2014 May 23;32(25):3050-7. doi: 10.1016/j.vaccine.2014.03.049. Epub 2014 Apr 8.

11.

The Thr205 phosphorylation site within respiratory syncytial virus matrix (M) protein modulates M oligomerization and virus production.

Bajorek M, Caly L, Tran KC, Maertens GN, Tripp RA, Bacharach E, Teng MN, Ghildyal R, Jans DA.

J Virol. 2014 Jun;88(11):6380-93. doi: 10.1128/JVI.03856-13. Epub 2014 Mar 26.

12.

The respiratory syncytial virus (RSV) nonstructural proteins mediate RSV suppression of glucocorticoid receptor transactivation.

Webster Marketon JI, Corry J, Teng MN.

Virology. 2014 Jan 20;449:62-9. doi: 10.1016/j.virol.2013.11.014. Epub 2013 Nov 26.

13.
14.

CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells.

Tian B, Zhao Y, Kalita M, Edeh CB, Paessler S, Casola A, Teng MN, Garofalo RP, Brasier AR.

J Virol. 2013 Jun;87(12):7075-92. doi: 10.1128/JVI.03399-12. Epub 2013 Apr 17.

15.

A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis.

Hotard AL, Shaikh FY, Lee S, Yan D, Teng MN, Plemper RK, Crowe JE Jr, Moore ML.

Virology. 2012 Dec 5;434(1):129-36. doi: 10.1016/j.virol.2012.09.022. Epub 2012 Oct 11.

16.

The interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biology.

Wu W, Tran KC, Teng MN, Heesom KJ, Matthews DA, Barr JN, Hiscox JA.

J Virol. 2012 Aug;86(15):7777-89. doi: 10.1128/JVI.00460-12. Epub 2012 May 16.

17.

The non-structural proteins of RSV: targeting interferon antagonists for vaccine development.

Teng MN.

Infect Disord Drug Targets. 2012 Apr;12(2):129-37. Review.

PMID:
22335499
18.

Roles of the respiratory syncytial virus trailer region: effects of mutations on genome production and stress granule formation.

Hanley LL, McGivern DR, Teng MN, Djang R, Collins PL, Fearns R.

Virology. 2010 Oct 25;406(2):241-52. doi: 10.1016/j.virol.2010.07.006. Epub 2010 Aug 10.

19.

The respiratory syncytial virus matrix protein possesses a Crm1-mediated nuclear export mechanism.

Ghildyal R, Ho A, Dias M, Soegiyono L, Bardin PG, Tran KC, Teng MN, Jans DA.

J Virol. 2009 Jun;83(11):5353-62. doi: 10.1128/JVI.02374-08. Epub 2009 Mar 18.

20.
21.

Purification and characterization of recombinant human respiratory syncytial virus nonstructural protein NS1.

Ling Z, Tran KC, Arnold JJ, Teng MN.

Protein Expr Purif. 2008 Feb;57(2):261-70. Epub 2007 Oct 1.

PMID:
17997327
22.

Akt plays a critical role in replication of nonsegmented negative-stranded RNA viruses.

Sun M, Fuentes SM, Timani K, Sun D, Murphy C, Lin Y, August A, Teng MN, He B.

J Virol. 2008 Jan;82(1):105-14. Epub 2007 Oct 24.

23.
24.

Function of the respiratory syncytial virus small hydrophobic protein.

Fuentes S, Tran KC, Luthra P, Teng MN, He B.

J Virol. 2007 Aug;81(15):8361-6. Epub 2007 May 9.

25.

Interaction between the respiratory syncytial virus G glycoprotein cytoplasmic domain and the matrix protein.

Ghildyal R, Li D, Peroulis I, Shields B, Bardin PG, Teng MN, Collins PL, Meanger J, Mills J.

J Gen Virol. 2005 Jul;86(Pt 7):1879-84.

PMID:
15958665
28.
29.

A role for immune complexes in enhanced respiratory syncytial virus disease.

Polack FP, Teng MN, Collins PL, Prince GA, Exner M, Regele H, Lirman DD, Rabold R, Hoffman SJ, Karp CL, Kleeberger SR, Wills-Karp M, Karron RA.

J Exp Med. 2002 Sep 16;196(6):859-65.

32.

Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees.

Teng MN, Whitehead SS, Bermingham A, St Claire M, Elkins WR, Murphy BR, Collins PL.

J Virol. 2000 Oct;74(19):9317-21.

33.
34.

Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics.

Collins PL, Whitehead SS, Bukreyev A, Fearns R, Teng MN, Juhasz K, Chanock RM, Murphy BR.

Adv Virus Res. 1999;54:423-51. Review.

PMID:
10547682
35.

Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees.

Whitehead SS, Bukreyev A, Teng MN, Firestone CY, St Claire M, Elkins WR, Collins PL, Murphy BR.

J Virol. 1999 Apr;73(4):3438-42.

38.
40.
41.

Experimental reproduction of severe hypoglycemia and spiking mortality syndrome using field-derived and embryo-passaged preparations.

Davis JF, Castro AE, de la Torre JC, Barnes HJ, Doman JT, Metz M, Lu H, Yuen S, Dunn PA, Teng MN.

Avian Dis. 1996 Jan-Mar;40(1):158-72.

PMID:
8713030
42.

Prevention of runting and cachexia by a chimeric TNF receptor-Fc protein.

Teng MN, Turksen K, Jacobs CA, Fuchs E, Schreiber H.

Clin Immunol Immunopathol. 1993 Nov;69(2):215-22.

PMID:
8403559
43.

Alternatively spliced ltk mRNA in neurons predicts a receptor with a larger putative extracellular domain.

Haase VH, Snijders AJ, Cooke SM, Teng MN, Kaul D, Le Beau MM, Bruns GA, Bernards A.

Oncogene. 1991 Dec;6(12):2319-25.

PMID:
1662793
44.

Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity.

Teng MN, Park BH, Koeppen HK, Tracey KJ, Fendly BM, Schreiber H.

Proc Natl Acad Sci U S A. 1991 May 1;88(9):3535-9.

Supplemental Content

Support Center